Flint Andersen, left, founder of the nonprofit Parents & Addicts in Need (PAIN), made an introduction between Beverly Raine with Kings View (center) and Dino Miliotis that led the adoption of the OpiAid wearable device. Linkedin photo

Just weeks after partnering with Hanford recovery center New Perceptions North, OpiAid — a company using wearable technology and AI to track real-time biometric data — has teamed up with Kings View Professional Services, one of California’s largest recovery service providers.

The deal could serve as a model for addiction recovery in California and beyond.

The wearable technology, developed by OpiAid in 2018, monitors triggers of potential substance abuse such as anxiety, withdrawal and depression every five minutes. That allows clinicians to respond quickly rather than relying on traditional techniques.

“It’s making recovery better,” said OpiAid spokesperson Dino Miliotis. “We saw that right away with the very first clinic that we licensed to.”

Since partnering with New Perceptions North in June, Miliotis said other clinics have jumped on board, describing early results as “stunning.” Kings View’s reach — serving 35 counties throughout California — made the new partnership a natural fit.

“You’re a well-known, trusted brand,” Miliotis said. “That is not something you gain overnight.”

Founded in Reedley in 1951, Kings View treats nearly 90,000 cases annually, offering mental health, telepsychiatry, substance use disorder treatment, crisis intervention and housing support. Executive Director of Telepsychiatry Beverly Raine said the platform will help clinicians deliver personalized care.

“This partnership will make a profound difference in how recovery is supported,” Raine said. “By equipping clinicians with real-time data, we are elevating care to a new level — giving clients the kind of personalized monitoring and support that can dramatically change outcomes.”

Miliotis, who has shared his own recovery experiences, criticized the industry’s reliance on one-size-fits-all treatment.

“For the most part, everybody was treated the same,” he said. “It doesn’t matter what drug of choice you had or it doesn’t matter what gender you were…take two pills and call me in the morning.”

He compared relapse rates to an unacceptable risk in any other context. “If you were driving and you were guaranteed that six out of ten or nine out of ten times you’re in a car. you’re guaranteed that you’re gonna crash…would you do it?”

OpiAid’s approach mimics professional athletics, he added: “Athletes return to peak performance in days because they’re monitored around the clock…That’s exactly what we’re now bringing to addiction recovery.”

Miliotis estimated the Kings View partnership could soon serve 10,000 unique cases per month.

“We’re going to be delivering state-of-the-art care with one of the top-flight organizations in the country, which is just music to my ears,” he said.

---

See an expanded version of this story in the Friday, Sept. 19, 2025 print edition of The Business Journal.